Who Paid My Doc
Matthew Ebling
Adolescent Medicine Lancaster, PA Medical Doctor
NPI 1770534075 CMS profile 499248
250 College Ave, Lancaster, PA 17603
General payments
$37
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Matthew Ebling of Lancaster, PA is reported in the CMS Open Payments database as having received $37 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $37 | 1 |
Beside peers
- Matthew Ebling
- Adolescent Medicine median
- Middle half of Adolescent Medicine
- National median
In program year 2025, general payments to Matthew Ebling were reported at $0. Among 40 Adolescent Medicine profiles paid that year, the median was $135 and the middle half received between $78 and $573.
Show as a table
| Year | Matthew Ebling | Adolescent Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $112 | $24–$444 | $163 |
| 2020 | $0 | $80 | $35–$250 | $114 |
| 2021 | $0 | $229 | $55–$448 | $132 |
| 2022 | $0 | $162 | $35–$492 | $149 |
| 2023 | $0 | $182 | $54–$507 | $160 |
| 2024 | $37 | $142 | $59–$362 | $164 |
| 2025 | $0 | $135 | $78–$573 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 7 drugsPart D claims
180
Drug cost
$1,866
Branded share of claims
23.3%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | Brand | 20 | $536 | |
| Naproxen | Generic | 60 | $433 | |
| Cefdinir | Generic | 19 | $305 | |
| Methylprednisolone | Generic | 44 | $281 | |
| Clindamycin Hcl | Generic | 15 | $126 | |
| Cefuroxime Cefuroxime Axetil | Brand | 11 | $117 | |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | Brand | 11 | $69 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 40,243 Part D prescribers listed as Emergency Medicine; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 18 billing codesPaid by Medicare
$24,999
Medicare patients
191
Services billed
270
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 51% | |
| Diabetes | 49% | |
| Ischemic heart disease | 41% | |
| Heart failure | 31% | |
| Chronic kidney disease | 31% | |
| Depression | 28% | |
| COPD | 27% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Adolescent Medicine in Pennsylvania
Joan Addley
Adolescent Medicine · Philadelphia, PA
Joseph Trompeter
Adolescent Medicine · Carnegie, PA
Gerard Margiotti
Adolescent Medicine · Trevose, PA
George Kochik
Adolescent Medicine · Wexford, PA
Gregory Anderson
Adolescent Medicine · Pittsburgh, PA
Amy Hursh
Adolescent Medicine · Pittsburgh, PA
Related records
Adolescent Medicine in Pennsylvania
Practitioners in the same specialty and state, ranked by reported value.
All Adolescent Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Pennsylvania
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.